Our 90-plus years of work in strategy and corporate finance have led us to develop innovative tools and approaches to help our clients stay ahead of the curve. We work with medical-technology companies to implement initiatives across portfolio strategy, innovation, growth strategy, transactions, due diligence, divestments, and activist-investor defense. Our deep understanding of value pools and trends in the industry coupled with our knowledge of disease treatments and health systems help clients build winning strategies.